Genetic screening for RET mutations in families with multiple endocrine neoplasia 2 syndromes

Annals of the New York Academy of Sciences

Volumn 816, Issue , 1997, Pages 383-388

  Alevizaki, M ^a   Sarika, H ^a   Koutras, D A ^a   Souvatzoglou, A ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; DNA;

ADOLESCENT; CLINICAL ARTICLE; CONFERENCE PAPER; DNA DETERMINATION; ETHNIC GROUP; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GREECE; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE RET; PROGNOSIS; PROTO ONCOGENE; PROVOCATION TEST; RISK;

EID: 0030806345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52166.x     Document Type: Conference Paper

References (23)

1. ENG, C., M. STRATTON, B. PONDER, V MURDAY, D. EASTON, N. SACKS, M. WATSON & R. EELES. 1994. Familial cancer syndromes. Lancet 343: 709-713.
2. MULLIGAN, L. M. & B. A. J. PONDER. 1995. Genetic basis of endocrine disease: Multiple endocrine neoplasia type 2. J. Clin. Endocrinol. Metab. 80: 1989-1995.
3. MARSH, D. J., D. L. LEAROYD & B. G. ROBINSON. 1995. Medullary thyroid carcinoma: Recent advances and management update. Thyroid 5: 407-423.
4. THAKKER, R. V 1993. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin. Endocrinol. 38: 1-14.
5. PONDER, B. A. J, B. A. SMITH, E. M. MARCUS, Y. NAKAMURA, R. M. LANDSVATER, C. H. C. M. BUYS & C. P. G. MATHEW. 1989. Genetic events in tumorigenesis in multiple endocrine neoplasia type 2. Cancer Cells 7: 219-221.
6. MATTHEW, C. G., K. S. CHIN, D. F EASTON, K. THORPE, C. CARTER, G. I. LIOU, S. L. FONG, C. D. BRODGES, K. HAAK, et al. 1987. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328: 527-528.
7. LAIRMORE, T. C., S. DOU, J. R. HOWE, D. CHI, K. CARLSON, R. VEILE, S. K. MISHRA, S. A. WELLS & H. DONIS KELLER. 1993. A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus. Proc. Natl. Acad. Sci. USA 90: 492-496.
8. MULLIGAN, L. M., J. B. KWOK, C. S. HEALEY, M. J. ELSDON, C. ENG, E. GARDNER, D. R. LOVE, S. E. MOLE, J. K. MOORE, L. PAPI, M. A. PONDER, H. TELENIUS, A. TUNNACLIFFE & B. A. J. PONDER. 1993. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460.
9. DONIS-KELLER, H., S. DOU, D. CHI, et al 1993. Mutations in the RET protooncogene are associated with MEN2A and FMTC. Hum. Molec. Genet. 2: 851-856.
10. MULLIGAN, L. M., C. ENG, C. S. HEALEY, D. CLAYTON, J. B. J. KWOK, E. GARDNER, M. A. PONDER, A. FRILLING, C. E. JACKSON, H. LEHNERT, H. P. H. NEUMANN, S. N. THIBODEAU & B. A. J. PONDER. 1994. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nature Genet. 6: 70-74.
11. HOFSTRA, R. M. W, R. M. LANDSVATER, I. CACCHERINI, R. P. STULP, T. STELWAGEN, Y. LUO, B. PASINI, J. W. M. HOPPENER, H. K. P. VANAMSTEL, G. ROMEO, C. J. M. LIPS & C. H. C. M. BUYS. 1994. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375-378.
12. ENG, C., D. P. SMITH, L. M. MULLIGAN, M. A. NAGAI, C. S. HEALEY, M. A. PONDER, E. GARDNER, G. F. W. SCHEUMANN, C. E. JACKSON, A. TUNNACLIFFE & B. A. J. PONDER. 1994. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum. Mol. Genet. 3: 237-241.
13. DURBEC, P., C. V MARCOS GUTIERREZ, C. KILKENNY, M. GRIGORIOU, K. WARTIOWAARA, P. SUVANTO, D. SMITH, B. PONDER, F. COSTANTINI, M. SAARMA, H. SARIOLA & V. PACHNIS. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789-793.
14. ZEDENIUS, J., C. LARSSON, U. BERGHOLM, J. BOVEE, A. SVENSSON, B. HALLENGREN, L. GRIMELIUS, M. BACKDAHL, G. WEBER & G. WALLIN. 1995. Mutations in the RET protooncogene correlate to poor prognosis in sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 80: 3088-3090.
15. GRIECO, M., M. SANTORO, M. T. BERLINGIERI, et al. 1990. PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinoma. Cell 60: 557-563.
16. LIPS, C. J. M., R. M. LANDSVATER, J. W. M. HOPPENER, R. A. GEERDINK, G. BLIJHAM, J. M. JANSEN-SCHILLHORN VAN HEEN, et al. 1994. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med. 331: 828-835.
17. MULLIGAN, L. M., D. J. MARSH, D. G. ROBINSON, I. SCHUFFENECKER, J. ZEDENIUS, C. J. M. LIPS, et al. 1995. Genotype-phenotype correlation in MEN2: Report of the international RET mutation registry. J. Intern. Med. 238: 343-346.
18. CARLSON, K. M., S. DOU, D. CHI, N. SCAVARDA, K. TOSHIMA, C. E. JACKSON, S. A. WELLS, P. J. GOODFELLOW & H. DONIS-KELLER. 1994. Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. 91: 1579-1583.
19. SANTORO, M., F. CARLOMAGNO, A. ROMANO, D. P. BOTTATO, N. A. DATHAN, M. GRIECO, A. Fusco, et al. 1995. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267: 381-383.
20. QUADRO, L., L. PANARIELLO, D. SALVATORE, F. CARLOMAGNO, M. DEL PRETE, V. NUNZIATA, V. COLABTUONI, G. DI GIOVANNI, L. M. BRANDI, M. MANELLI, M. GRIECO & M. SANTORO. 1994. Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 79: 590-594.
21. WELLS, S. A., D. D. CHI, K. TOSHIMA, L. P. DEHNER, C. M. COFFIN, B. DOWTON, et al. 1994. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann. Surg. 220: 237-250.
22. ALEVIZAKI, M., L. SARIKA, G. PHILIPPOU, S. I. GRIGORAKIS, P. PAPAPETROU, A. SOUVATZOGLOU & D. A. KOUTRAS. 1995. Study of the MEN2A "gene" in Greek patients with familial medullary thyroid carcinoma (MTC) and related syndromes. 8th Balkan Congress of Endocrinology, Abstract Book p. 242. Buna. May 1995.
23. JHIANG, S. M., J. E. SAGARTZ, Q. TONG, J. PARKER-THORNBURG, C. C. CAPEN, J. Y. CHO, S. XING & C. LEDENT. 1996. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378.